Co-Authors
This is a "connection" page, showing publications co-authored by Manfredi Rizzo and Anca Stoian.
Connection Strength
3.205
-
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):494-496.
Score: 0.890
-
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175.
Score: 0.876
-
Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int J Clin Pract. 2021 02; 75(2):e13666.
Score: 0.457
-
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism. Expert Opin Drug Saf. 2021 Nov; 20(11):1309-1315.
Score: 0.241
-
Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care. Medicina (Kaunas). 2021 Aug 06; 57(8).
Score: 0.240
-
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story. Diabetes Metab Res Rev. 2021 02; 37(2):e3379.
Score: 0.223
-
COVID-19 and diabetes management: What should be considered? Diabetes Res Clin Pract. 2020 05; 163:108151.
Score: 0.219
-
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study. Sci Rep. 2020 12 10; 10(1):21613.
Score: 0.057